NQF Distances Itself From Safe Practices Co-Chair
According to an NQF statement released late Wednesday, the NQF not only severed its relationship with Denham in March of 2010, but it declined further financial support from Denham's foundation, the non-profit Texas Medical Institute of Technology, which had given the NQF $725,000 between 2006 and 2010 for special projects. In addition, the NQF
- Now refuses to enter grant agreements where a funder is on an endorsement committee, even as a non-voting member
- Has reviewed other committee reports that Denham was involved in to be certain that he did not influence their outcomes, and
- Has updated its conflict of interest policy
Denham: Reports Are 'Blatantly False'
I tried to reach Denham directly to hear his side of the story, but instead received an e-mailed statement from his spokesman. It says allegations that CareFusion paid $11.6 million in improper kickbacks to Denham while he was NQF Safe Practices Committee co-chair "are blatantly false reports."
"The qui tam complaint involved in the settlement between the government and CareFusion makes absolutely no mention of Dr. Denham, and does not involve him or any of his companies in any way. The (whistleblower) action revolved around CareFusion's alleged off-label promotion of one of its products."
Rather, it is the executed settlement agreement, which HealthLeaders Media obtained Wednesday from the Department of Justice, that details the accusations against Denham.
- Ratcheting Up Patient Experience Has a Downside
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Narrow Networks Enjoying a Resurgence
- Physicians Trained in High-Cost Regions Spend More
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- HL20: Lee Aase—Who's Behind @MayoClinic
- Christmas Tree Syndrome Season Underway
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- Population Health Starts with Ending Hunger
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach